Skip to main content
Premium Trial:

Request an Annual Quote

Roche Diagnostics to Spend $135M on Expansion in Indianapolis; 600 New Jobs Planned

NEW YORK, April 17 - Roche Diagnostics will invest more than $135 million in its Indianapolis facility as it embarks on a plan to expand R&D, laboratory, manufacturing, distribution, and information-technology operations.


The expansion, which is expected to create around 600 new jobs at the Indianapolis campus over the ensuing 10 years, is intended to support growth in the company's five diagnostics business areas: diabetes, central diagnostics, applied sciences, molecular diagnostics, and point of care.


In return for these "business improvements," Roche Diagnostics said it will receive over the next 10 years up to $22.2 million in local and state "economic-development incentives" in the form of state corporate income tax credits, training grants, property tax abatement savings, and public infrastructure improvements.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.